Novartis Lifts FY23 View As Q2 Results Top Market, Initiates $15 Bln Buyback; Stock Up

Shares of Novartis AG were gaining around 4 percent in the morning trading in Switzerland as well as in pre-market activity on the NYSE after the drug major raised its fiscal 2023 outlook on Tuesday after reporting higher second-quarter results.

Related Keywords

Switzerland , United States , Swiss , American , , Novartis , Thomson Reuters , Swiss Exchange , Extraordinary General Meeting , American Depositary Receipt , Sandoz , Share Buyback , Pin Off , Drug Major , Market Estimates , Ovartis Earnings , Vas Narasimhan ,